Evidence map›Paper›PMID 31410054›Full record

ArticleBreast cancer (Dove Medical Press)2019

Beliefs held by breast surgeons that impact the treatment decision process for advanced breast cancer patients: a qualitative study.

Reina Ozeki-Hayashi, Misao Fujita, Atsushi Tsuchiya, Taichi Hatta, Eisuke Nakazawa, Yoshiyuki Takimoto, Akira Akabayashi

Open access · goldAbstract read
In one paragraph

Article in Breast cancer (Dove Medical Press), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact, top 89% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it, 2 citations in OpenAlex.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Reina Ozeki-HayashiDepartment of Biomedical Ethics, The University of Tokyo Faculty of Medicine, Tokyo, Japan.
Misao FujitaUehiro Research Division for iPS Cell Ethics, Center for iPS Cell Research and Application Kyoto University, Kyoto, Japan.
Atsushi TsuchiyaIndustrial and Social Science, Tokushima University Graduate School of Technology, Tokushima, Japan.
Taichi HattaUehiro Research Division for iPS Cell Ethics, Center for iPS Cell Research and Application Kyoto University, Kyoto, Japan.
Eisuke NakazawaDepartment of Biomedical Ethics, The University of Tokyo Faculty of Medicine, Tokyo, Japan.
Yoshiyuki TakimotoDepartment of Biomedical Ethics, The University of Tokyo Faculty of Medicine, Tokyo, Japan.
Akira AkabayashiDepartment of Biomedical Ethics, The University of Tokyo Faculty of Medicine, Tokyo, Japan.
The University of Tokyo · JPKyoto University · JPNew York University · USTokushima University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAlthough guidelines do not recommend chemotherapy for patients with advanced cancer when death is imminent, many reports suggest the tendency to continue this treatment has been increasing every year. This study aimed to construct a model to clarify the beliefs and communication of doctors who administer chemotherapy to patients with recurrent or metastatic (hereafter, "recurrent/metastatic") breast cancer, and determine how these beliefs are related to the process of treating patients. MATERIALS AND

methodsSemi-structured interviews were conducted with 21 breast surgeons, and interview contents were analyzed using the grounded theory approach in order to conceptualize the treatment process.

resultsThe process of chemotherapy for patients with recurrent/metastatic breast cancer differed based on two beliefs held by doctors. One was a "belief that the patient is an entity who cannot accept death," and throughout the treatment process, these doctors consistently avoided sharing bad news that might hurt patients, and always discussed aggressive chemotherapy. They proposed treatments as long as options remained, and when they ultimately judged that the physical condition of patients could not withstand further treatment, treatment was terminated despite the patient hoping for continuation. The other was a "belief that the patient is an entity who can accept death." From early on after recurrence/metastasis, these doctors repeatedly gave patients information including bad news about prognosis, and when they judged that further treatment would hinder a patient's ability to have a good death, they proposed terminating treatment.

conclusionWe demonstrated that breast surgeons treating recurrent/metastatic breast cancer patients have two beliefs and constructed a model of the treatment process based on those beliefs. This offered breast surgeons, who make decisions regarding treatment without clearly-defined guidelines, a chance to reflect on their own care style, which we believe will contribute to optimal patient care.

Indexed as

decision-making processend-of-lifepalliative chemotherapyqualitative research

Identifiers

PMID31410054
PMCPMC6645069
OpenAlexW2960954452

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.